CCL3L1 and HIV/AIDS susceptibility.
Bhattacharya
Tanmoy
T
Stanton
Jennifer
J
Kim
Eun-Young
EY
Kunstman
Kevin J
KJ
Phair
John P
JP
Jacobson
Lisa P
LP
Wolinsky
Steven M
SM
D000163:Acquired Immunodeficiency Syndrome / Q000235:genetics*; D000349:Africa / Q000453:epidemiology; D019742:Chemokines, CC / Q000235:genetics* / Q000378:metabolism; D015331:Cohort Studies; D018450:Disease Progression; D005006:Ethnicity / Q000235:genetics; D005060:Europe / Q000453:epidemiology; D005260:Female; D018628:Gene Dosage; D020022:Genetic Predisposition to Disease; D014644:Genetic Variation; D005838:Genotype; D015658:HIV Infections / Q000453:epidemiology / Q000235:genetics* / Q000276:immunology / Q000821:virology; D015497:HIV-1 / Q000378:metabolism*; D006801:Humans; D008024:Ligands; D008297:Male; D011110:Polymorphism, Genetic; D012333:RNA, Messenger / Q000378:metabolism; D044469:Racial Groups / Q000235:genetics; D019713:Receptors, CCR5 / Q000235:genetics; D012307:Risk Factors; D019562:Viral Load
C492767:CCL3L1 protein, human; D019742:Chemokines, CC; D008024:Ligands; D012333:RNA, Messenger; D019713:Receptors, CCR5